|
ZNF652 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.229700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.143800E-03 |
| Normal-vs-Stage2 |
2.177600E-01 |
| Normal-vs-Stage3 |
1.439010E-01 |
| Normal-vs-Stage4 |
1.209160E-01 |
| Stage1-vs-Stage2 |
8.667800E-01 |
| Stage1-vs-Stage3 |
5.928200E-01 |
| Stage1-vs-Stage4 |
4.221400E-01 |
| Stage2-vs-Stage3 |
8.297600E-01 |
| Stage2-vs-Stage4 |
3.959200E-01 |
| Stage3-vs-Stage4 |
3.296800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.843110E-03 |
| Normal-vs-AfricanAmerican |
1.242060E-03 |
| Normal-vs-Asian |
1.761640E-01 |
| Caucasian-vs-AfricanAmerican |
3.233000E-01 |
| Caucasian-vs-Asian |
3.567200E-01 |
| AfricanAmerican-vs-Asian |
2.363800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.843900E-04 |
| Normal-vs-Female |
1.003480E-03 |
| Male-vs-Female |
3.909200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.489410E-01 |
| Normal-vs-Extreme_Weight |
8.439800E-03 |
| Normal-vs-Obese |
1.540020E-03 |
| Normal-vs-Extreme_Obese |
2.325800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.444800E-01 |
| Normal_Weight-vs-Obese |
1.948180E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.543400E-01 |
| Extreme_Weight-vs-Obese |
3.404400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.659800E-01 |
| Obese-vs-Extreme_Obese |
3.970800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.67010000000123E-05 |
| Normal-vs-Age(41-60Yrs) |
2.46900000000494E-06 |
| Normal-vs-Age(61-80Yrs) |
7.905700E-02 |
| Normal-vs-Age(81-100Yrs) |
8.457800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.576300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.643350E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.318470E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.919320E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.216140E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.373600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.30100000456702E-08 |
| Normal-VS-Type2 PRCC |
1.486390E-01 |
| Normal-VS-KIRP CIMP |
5.276200E-03 |
| Normal-VS-Unclassified PRCC |
3.054000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.69000402350639E-11 |
| Type1 PRCC-VS-KIRP CIMP |
7.599700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.279840E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.23649999997466E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
1.076040E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.352000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.027600E-01 |
| Normal-vs-N1 |
1.129930E-02 |
| Normal-vs-N2 |
1.662990E-01 |
| N0-vs-N1 |
6.668100E-02 |
| N0-vs-N2 |
5.402100E-02 |
| N1-vs-N2 |
5.787200E-01 |
|
|
